More than a half dozen clinical trials over the past decade have evaluated the effects of myo-inositol combined with folic acid on women. Published research includes a randomized, double-blind study by Gerli et al., which compared results for women taking myo-inositol and folic acid, versus women taking only folic acid. The study found that women taking both myo-inositol and folic acid ovulated more quickly and more frequently. In another example of published research, a randomized, double-blind study by Ciotta et al. found that women taking myo-inositol and folic acid had greater numbers of follicles of a desirable size and produced significantly more oocyte eggs than women taking only folic acid.
"Consumers have a strong interest in fertility products, such as Pregnitude," said Eduardo Fernandez, Vice President -Business Operations & Consumer Brands for Exeltis USA, Inc., the distributor of Pregnitude in the US. "This demand has enabled up to expand the number of retail and online outlets carrying Pregnitude," adds Fernandez. Pregnitude is available without a prescription through pharmacy and online retailers, including: select Walgreens stores and Walgreens.com; select CVS stores and CVS.com; Drugstore.com; FSAstore.com; Amazon.com; BabyHopes.com and Pregntiude.com.
About Exeltis USA, Inc.
Exeltis USA, Inc. (formerly Everett Laboratories) is committed to improving women's health at all stages of life (contraception, pregnancy, fertility and menopause) and offers an extensive portfolio of products to meet women's reproductive health needs and help improve wellbeing and quality of life. For more information, please visit: http://womenshealth.exeltisusa.com/.
The statements in this product briefing have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/studies-show-fertility-dietary-supplement-supports-reproductive-health-300294844.html
SOURCE Exeltis USA, Inc.